Foresite Capital Management IV as of June 30, 2023
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 7 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pharvaris N V (PHVS) | 27.9 | $57M | 3.7M | 15.14 | |
| Lyell Immunopharma (LYEL) | 15.2 | $31M | 9.7M | 3.18 | |
| Kinnate Biopharma | 14.4 | $29M | 9.7M | 3.03 | |
| Aclaris Therapeutics (ACRS) | 14.3 | $29M | 2.8M | 10.37 | |
| Kura Oncology (KURA) | 9.6 | $20M | 1.8M | 10.58 | |
| Cymabay Therapeutics | 9.6 | $20M | 1.8M | 10.95 | |
| Syndax Pharmaceuticals (SNDX) | 9.0 | $18M | 875k | 20.93 |
